Search PubMed⌕ Search

Biomedical subjects

H Nishida

Publications and source records attributed to H Nishida.

At least 469 records · Page 26Linked to original sources
PubMed1985

Experimental studies on aclacinomycin.

Experimental features of aclacinomycin (ACM), a new antitumour antibiotic of the anthracycline group, are presented. ACM inhibited the growth of experimental mouse tumours and human cancer xenografts from various origins. In CDF1 mice with L1210 cells treated i.p. with ACM in combination with Ara-C for 10 days, a 459% ILS was observed, including 67% of 60-day survivors. The inhibition of RNA and DNA synthesis was examined in L1210 cells. The IC50 values of ACM for incorporations of [14C]-thymidine and [14C]-uridine were 0.30 and 0.038 microgram/ml respectively. The ratio of IC50. DNA/RNA was 7.9, while with adriamycin (ADR) it was 2.5. ACM showed no mutagenic activity in the Ames' test and the rec- assay. The cardiac toxicity of ACM was significantly lower than that of ADR. Lower ECG changes, a return to normal after discontinuation of the drug and slighter ultrastructural modifications of the myocardium were demonstrated in hamsters and rabbits. When administered to hamsters i.v. at 5 mg/kg, ACM was eliminated almost completely from the heart muscle after 2 h, while ADR remained at 8 micrograms/g even after 8 h.

Aclarubicin↗
PubMed1985

[Surgical treatment of infective endocarditis--decision tree for the treatment and introduction of translocation method].

Persistent fever during active-phase IE is an indication for surgical treatment in the light of the causative organism and the underlying disease. To counter worsening hemodynamics, surgery may be the only feasible way. Surgery is performed when the patient does not respond to vasodilators and he shows FS of less than 25%. The introduction of translocation provides a solution for the treatment of active IE. Lesions, vegetations more than 5mm in diameter, periannular abscess, and mycotic aneurysm that could never be overlooked by two-dimensional echocardiography may hasten the early stage decision of ways to treat IE.

Adult↗
PubMed1984

Clinical results of radiofrequency hyperthermia combined with radiation in the treatment of radioresistant cancers.

Clinical results of radiothermotherapy applied to 40 radioresistant tumors in 36 patients were reported. Hyperthermia was administered locally using two radiofrequency (RF) capacitive heating equipment systems developed in our institution under the collaboration of Yamamoto Vinyter Co. Ltd. Hyperthermia was given twice weekly immediately after irradiation. Intratumor temperatures of 41 degrees C to 44 degrees C were maintained for 30 to 60 minutes. Radiation doses varied from 32 Gy to 60 Gy. Of the 40 tumors treated, 21 (53%) showed complete response, 16 (40%) partial response, and 3 (7%) no response when the tumor response was assessed by tumor size measurement. Of eight patients who had matched tumors treated with either radiation alone or radiation plus hyperthermia, six patients showed better response in tumors treated with radiothermotherapy than in tumors treated with radiation alone. Skin reactions following radiothermotherapy and radiation alone were comparable. The tumor response was greatly dependent on the tumor size. Greater response was observed in small tumors, although histologic examinations and long-term follow-up studies revealed an excellent effect of radiothermotherapy on the large tumors as well as on the small tumors. Tumor responses correlated with tumor center temperatures but not with histologic features. Our clinical results indicate that RF hyperthermia combined with radiation has a therapeutic benefit in the treatment of radioresistant cancers.

Body Temperature↗
PubMed1984

Peripheral arterial contrast echocardiography: a new method for the detection of left-to-right shunting patent ductus arteriosus.

A modified echocardiographic method (peripheral arterial contrast echocardiography, PACE) using suprasternal notch (SSN) echocardiography and rapid hand injection of 5% glucose solution through peripheral arteries is introduced. This method was used to determine the presence of a left-to-right shunting via patent ductus arteriosus (PDA) in 50 patients with various congenital heart disease among neonates, infants, and young children. Echocardiographic findings were compared with cardiac catheterization/angiography, surgery, and/or autopsy. Diagnosis of PDA made by PACE was sensitive in 98.5% and specific in 100% of cases. Thus, the PACE examination is a reliable bed-side technique to detect qualitatively the presence or absence of a left-to-right shunting PDA accompanied with acyanotic or cyanotic heart disease.

Child, Preschool↗
PubMed1984

Autonomous muscle cell differentiation in partial ascidian embryos according to the newly verified cell lineages.

Recent analysis of cell lineages in ascidian embryos by the intracellular injection of a tracer enzyme has clearly demonstrated that muscle cells are derived not only from the B4.1-cell pair of the eight-cell stage embryo, as has hitherto been believed, but also from both the b4.2- and A4.1-cell pairs (H. Nishida and N. Satoh, 1983, Dev. Biol. 99, 382-394). In order to reexamine the developmental autonomy in muscle lineage cells, the B4.1 pair was isolated from the eight-cell stage embryo. The progeny cells of the B4.1 pair, as well as those of the six other blastomeres, were then allowed to develop in isolation into partial embryos. Autonomous muscle cell differentiation not only in partial embryos originating from the B4.1 cells but also in those from the six other blastomeres was substantiated by (a) occurrence of localized histospecific muscle acetylcholinesterase and (b) development of myofibrils. These results support the validity of the recent cell lineage study and confirmed the self-differentiation potency of muscle lineage cells in ascidian embryos according to the newly verified cell lineages.

Acetylcholinesterase↗